Word

X-60

Status

Dead

Status Code

606

Status Date

Monday, November 7, 2022

Serial Number

88431149

Mark Type

4000

Filing Date

Wednesday, May 15, 2019

Published for Opposition

Tuesday, February 11, 2020

Abandoned Date

Monday, November 7, 2022

Trademark Owner History

Essenlix Corporation - Owner At Publication

Classifications

5 Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases

1 Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, or diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use

44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing health and wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing in the nature of the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases, diagnostic testing, namely, medical testing for diagnostic purposes, and wellness services, namely, providing wellness information in the fields of health and wellness, all of the foregoing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes

10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point- of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes

X SIXTY

Trademark Events

Nov 7, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Nov 7, 2022

Abandonment - No Use Statement Filed

Apr 2, 2022

Notice Of Approval Of Extension Request E-Mailed

Mar 31, 2022

Sou Extension 4 Granted

Mar 31, 2022

Sou Extension 4 Filed

Mar 31, 2022

Sou Teas Extension Received

Oct 6, 2021

Notice Of Approval Of Extension Request E-Mailed

Oct 4, 2021

Sou Extension 3 Granted

Oct 4, 2021

Sou Extension 3 Filed

Oct 4, 2021

Sou Teas Extension Received

Apr 2, 2021

Notice Of Approval Of Extension Request E-Mailed

Mar 31, 2021

Sou Extension 2 Granted

Mar 31, 2021

Sou Extension 2 Filed

Mar 31, 2021

Sou Teas Extension Received

Oct 1, 2020

Notice Of Approval Of Extension Request E-Mailed

Sep 29, 2020

Sou Extension 1 Granted

Sep 29, 2020

Sou Extension 1 Filed

Sep 29, 2020

Sou Teas Extension Received

Apr 7, 2020

Noa E-Mailed - Sou Required From Applicant

Feb 11, 2020

Official Gazette Publication Confirmation E-Mailed

Feb 11, 2020

Published For Opposition

Jan 22, 2020

Notification Of Notice Of Publication E-Mailed

Jan 5, 2020

Approved For Pub - Principal Register

Dec 31, 2019

Teas/Email Correspondence Entered

Dec 31, 2019

Correspondence Received In Law Office

Dec 31, 2019

Assigned To Lie

Dec 10, 2019

Teas Response To Office Action Received

Jun 13, 2019

Notification Of Non-Final Action E-Mailed

Jun 13, 2019

Non-Final Action E-Mailed

Jun 13, 2019

Non-Final Action Written

Jun 11, 2019

Assigned To Examiner

May 31, 2019

New Application Office Supplied Data Entered

May 18, 2019

New Application Entered